Monday 20 March | |
Aukett Swanke Group PLC | GM re proposed acquisition of Torpedo Factory Group Ltd |
Pantheon Resources PLC | AGM |
Voyager Life PLC | GM re subscription and fundraise |
Tuesday 21 March | |
BlackRock Sustainable American Income Trust PLC | AGM |
Gresham House Renewable Energy VCT 2 PLC | AGM |
React Group PLC | AGM |
Starvest PLC | AGM |
Sureserve Group PLC | AGM |
Wynnstay Group PLC | AGM |
Zamaz PLC | GM re terms and conditions modification |
Wednesday 22 March | |
abrdn Private Equity Opportunities Trust PLC | AGM |
Asia Strategic Holdings Ltd | AGM |
Circle Property PLC | EGM re final disposal and cancellation |
Genel Energy PLC | AGM |
Harmony Energy Income Trust PLC | AGM |
Titon Holdings PLC | AGM |
Thursday 23 March | |
Crest Nicholson Holdings PLC | AGM |
Driver Group PLC | AGM |
Goldplat PLC | AGM |
Hardide PLC | AGM |
Idox PLC | AGM |
Zaim Credit Systems PLC | GM re director removal and name change |
Friday 24 March | |
Faron Pharmaceuticals Ltd | AGM |
In The Style Group PLC | GM re sale of only subsidiary; becoming cash shell named Itsum PLC |
Kitwave Group PLC | AGM |
Midatech Pharma PLC | GM re cancellation of the admission to trading on AIM and name change |
SME Credit Realisation Fund Ltd | EGM re cancellation of the company's listing |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
IN BRIEF: Faron Pharmaceuticals starts Phase 2 of Bexmab trial
Faron Pharmaceuticals Ltd - Finland-based clinical-stage biopharmaceutical company - Initiates Phase 2 of Bexmab study investigating humanised antibody bexmarilimab in patients with aggressive myeloid leukemias. Says it has selected hypomethylating agents-refractory or relapsed myelodysplastic syndromes (MDS) as the initial indication, based on US Food & Drug Administration guidance. Phase 1 data "demonstrated that optimal target engagement can be achieved with three milligrams per kilogram dosing" with both three and six milligram cohorts showing the "highest immune activation", while the drug produced a 50% remission rate in doublet dose cohorts.
Read more